Campbell & CO Investment Adviser LLC Cerus Corp Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$5.97 - $7.93 $284,172 - $377,468	-47,600 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$4.79 - $6.68 $228,004 - $317,968	47,600 New	47,600 $290,000
Q2 2019 Jul 10, 2019	SELL	$4.51 - $6.6 $132,819 - $194,370	-29,450 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$5.16 - $6.85 $15,645 - $20,769	-3,032 Reduced 9.33%	29,450 $183,000
Q4 2018 Feb 08, 2019	SELL	$4.89 - $7.16 $215,737 - $315,884	-44,118 Reduced 57.6%	32,482 $182,000
Q3 2018 Nov 08, 2018	BUY	$6.89 - $7.78 $157,781 - $178,162	22,900 Added 42.64%	76,600 $552,000
Q2 2018 Jul 13, 2018	BUY	$5.19 - $7.25 $278,703 - $389,325	53,700 New	53,700 $358,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.